Aerodigestive fistulas in adults treated at Strasbourg University Hospital
Official title: Aerodigestive Fistulas in Adults: Management at the Strasbourg University Hospital Between 2014 and 2023
Run by University Hospital, Strasbourg, France · NCT07299513 · Data updated 2026-11-12
This project looks at medical records of adults with acquired aerodigestive fistulas treated at Strasbourg between 2014 and 2023 to see what causes them, how they are diagnosed, and what happens afterward.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Status | Recruiting |
| Started | November 21, 2024 |
| Main results expected | November 2026 |
| Study ends | November 21, 2026 |
| Registry record updated | December 23, 2025 |
| Trial ID | NCT07299513 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over age 18 who were hospitalized at Strasbourg University Hospitals and diagnosed with an acquired aerodigestive fistula (confirmed by endoscopy or chest imaging) between January 1, 2014 and December 31, 2023.
✕Probably not a fit
People under 18, patients with congenital fistulas, those treated outside Strasbourg University Hospitals, or anyone who explicitly refuses data use are unlikely to be included or to directly benefit from this dataset.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a retrospective observational review of adult patients hospitalized at Strasbourg University Hospitals with acquired aerodigestive fistulas diagnosed from January 1, 2014 to December 31, 2023. Cases are identified by endoscopic or imaging confirmation (bronchoscopy, digestive endoscopy, chest CT/MRI, or barium swallow) and hospital records will be reviewed for presentation, etiology, diagnostic workup, management, and outcomes. The analysis will compare benign (largely iatrogenic) versus malignant causes and describe patterns of care and prognosis. Results are intended to summarize local experience and inform clinical decision-making for similar patients.
Why it matters
Potential benefit: If successful, the results could help clinicians recognize aerodigestive fistulas earlier and choose treatments that improve outcomes and quality of life.
How similar studies have gone: Previous case series and retrospective cohorts have described causes and outcomes of aerodigestive fistulas, so this work builds on established observational literature rather than testing a new therapy.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 18 years at diagnosis * Diagnosis between January 1, 2014, and December 31, 2023 * Aerodigestive fistula defined by one of the following criteria: * Fistula visualized by bronchoscopy and/or digestive endoscopy * Fistula visualized by static chest imaging (CT scan or MRI) * Fistula visualized by dynamic chest imaging (barium swallow) * Hospitalization at the Strasbourg University Hospitals (HUS) Exclusion Criteria: * Explicit refusal by the patient to provide their data
Where it's running
-
Service de Pneumologie - Hôpitaux Universitaires de Strasbourg
Strasbourg, France Recruiting
Study contacts
- Study coordinator: Guillaume PAMART, MD
- Email: guillaume.pamart@chru-strasbourg.fr
- Phone: 33 3/69/55/06/48
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.